Willingness to pay for antenatal carrier screening for cystic fibrosis

Cam Donaldson*, Phil Shackley, Mona Abdalla, Zosia Miedzybrodzka

*Corresponding author for this work

Research output: Contribution to journalArticle

82 Citations (Scopus)

Abstract

We report on a study of women's willingness to pay (WTP) for a cystic fibrosis carrier test by one or other method of service delivery (disclosure or non-disclosure). The results demonstrate that there was no statistically significant difference in WTP for the methods of testing. Those women who received a negative test result were followed up and asked their WTP for such a result. Values obtained at this stage were 16 per cent higher than those obtained pretest result. Use of prompts, rather than simply asking women to state their WTP, had a statistically significant effect on post-test result values. The opportunity to terminate the pregnancy, if a test proved positive, was important, but was not the only consideration. This demonstrates the importance to women of other benefits of screening.

Original languageEnglish
Pages (from-to)439-452
Number of pages14
JournalHealth Economics
Volume4
Issue number6
DOIs
Publication statusPublished - Dec 1995

Fingerprint

Prenatal Diagnosis
Cystic Fibrosis
Pregnancy Tests
Disclosure

Keywords

  • willingness to pay
  • antenatal screening
  • cystic fibrosis

ASJC Scopus subject areas

  • Health Policy

Cite this

Willingness to pay for antenatal carrier screening for cystic fibrosis. / Donaldson, Cam; Shackley, Phil; Abdalla, Mona; Miedzybrodzka, Zosia.

In: Health Economics, Vol. 4, No. 6, 12.1995, p. 439-452.

Research output: Contribution to journalArticle

Donaldson, Cam ; Shackley, Phil ; Abdalla, Mona ; Miedzybrodzka, Zosia. / Willingness to pay for antenatal carrier screening for cystic fibrosis. In: Health Economics. 1995 ; Vol. 4, No. 6. pp. 439-452.
@article{bc23929a759c4537bc9cc310b7de9dc6,
title = "Willingness to pay for antenatal carrier screening for cystic fibrosis",
abstract = "We report on a study of women's willingness to pay (WTP) for a cystic fibrosis carrier test by one or other method of service delivery (disclosure or non-disclosure). The results demonstrate that there was no statistically significant difference in WTP for the methods of testing. Those women who received a negative test result were followed up and asked their WTP for such a result. Values obtained at this stage were 16 per cent higher than those obtained pretest result. Use of prompts, rather than simply asking women to state their WTP, had a statistically significant effect on post-test result values. The opportunity to terminate the pregnancy, if a test proved positive, was important, but was not the only consideration. This demonstrates the importance to women of other benefits of screening.",
keywords = "willingness to pay, antenatal screening, cystic fibrosis",
author = "Cam Donaldson and Phil Shackley and Mona Abdalla and Zosia Miedzybrodzka",
note = "HERU and HSRU are funded by the Chief Scientist Office of the Scottish Office Home and Health Department (SOHHD). However, the opinions expressed in this paper are those of the authors, not SOHHD. The authors are also grateful to the Wellcome Trust for their funding of the CF screening project, to the other contributors to the study from Aberdeen Maternity Hospital, to colleagues in the Health Economists’ Study Group and two anonymous referees for comments on an earlier draft.",
year = "1995",
month = "12",
doi = "10.1002/hec.4730040602",
language = "English",
volume = "4",
pages = "439--452",
journal = "Health Economics",
issn = "1057-9230",
publisher = "John Wiley and Sons Ltd",
number = "6",

}

TY - JOUR

T1 - Willingness to pay for antenatal carrier screening for cystic fibrosis

AU - Donaldson, Cam

AU - Shackley, Phil

AU - Abdalla, Mona

AU - Miedzybrodzka, Zosia

N1 - HERU and HSRU are funded by the Chief Scientist Office of the Scottish Office Home and Health Department (SOHHD). However, the opinions expressed in this paper are those of the authors, not SOHHD. The authors are also grateful to the Wellcome Trust for their funding of the CF screening project, to the other contributors to the study from Aberdeen Maternity Hospital, to colleagues in the Health Economists’ Study Group and two anonymous referees for comments on an earlier draft.

PY - 1995/12

Y1 - 1995/12

N2 - We report on a study of women's willingness to pay (WTP) for a cystic fibrosis carrier test by one or other method of service delivery (disclosure or non-disclosure). The results demonstrate that there was no statistically significant difference in WTP for the methods of testing. Those women who received a negative test result were followed up and asked their WTP for such a result. Values obtained at this stage were 16 per cent higher than those obtained pretest result. Use of prompts, rather than simply asking women to state their WTP, had a statistically significant effect on post-test result values. The opportunity to terminate the pregnancy, if a test proved positive, was important, but was not the only consideration. This demonstrates the importance to women of other benefits of screening.

AB - We report on a study of women's willingness to pay (WTP) for a cystic fibrosis carrier test by one or other method of service delivery (disclosure or non-disclosure). The results demonstrate that there was no statistically significant difference in WTP for the methods of testing. Those women who received a negative test result were followed up and asked their WTP for such a result. Values obtained at this stage were 16 per cent higher than those obtained pretest result. Use of prompts, rather than simply asking women to state their WTP, had a statistically significant effect on post-test result values. The opportunity to terminate the pregnancy, if a test proved positive, was important, but was not the only consideration. This demonstrates the importance to women of other benefits of screening.

KW - willingness to pay

KW - antenatal screening

KW - cystic fibrosis

UR - http://www.scopus.com/inward/record.url?scp=0029399710&partnerID=8YFLogxK

U2 - 10.1002/hec.4730040602

DO - 10.1002/hec.4730040602

M3 - Article

VL - 4

SP - 439

EP - 452

JO - Health Economics

JF - Health Economics

SN - 1057-9230

IS - 6

ER -